PFE Stock DD Pfizer, Inc. 10/11/2014 21:54:03

New Post Public Reply Private Reply Replies (0) Message Board

Oct 11, 2014 at 10:53 PM

PFE Pfizer, Inc. $PFE Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=PFE&...mp;yt0=Go!

Last Updated: 10/11/2014 21:53:59

Current Price and Quotes
Last Price
Previous Close Open
Daily Range - 52wk Range -
Volume Dividend
Average Vol (30d) Yield

Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 51,584,000 54,657,000 61,035,000 65,165,000
Cost of Revenue 9,586,000 9,821,000 12,500,000 14,788,000
Gross Profit 41,998,000 44,836,000 48,535,000 50,377,000
Operating Expenses

Research and Development 6,678,000 7,482,000 8,681,000 9,483,000
Sales, General and Admin. 14,355,000 15,171,000 17,581,000 18,973,000
Non-Recurring Items 1,182,000 1,810,000 2,841,000 3,145,000
Other 4,599,000 5,109,000 5,465,000 5,364,000
Operating Income 15,184,000 15,264,000 13,967,000 13,412,000
Income From Continuing Operations

Add'l Income/Expense Items 532,000 (4,022,000) (2,486,000) (3,941,000)
Earnings Before Interest and Tax 15,716,000 11,242,000 11,481,000 9,471,000
Interest Expense - - - -
Earnings Before Tax 15,716,000 11,242,000 11,481,000 9,471,000
Income Tax 4,306,000 2,221,000 3,621,000 1,153,000
Minority Interest 69,000 28,000 40,000 31,000
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 11,410,000 9,021,000 7,860,000 8,318,000
Non Recurring Events

Discontinued Operations 10,662,000 5,577,000 2,189,000 (30,000)
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 22,003,000 14,570,000 10,009,000 8,257,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 22,003,000 14,570,000 10,009,000 8,257,000

Recent News

Oct 10, 2014 Marketing Application Update, Acquisitions, Collaborations, FDA Approvals, and Structural Changes - Research Reports on Gilead, BD, Pfizer, AbbVie and Novartis
Oct 10, 2014 Pfizer to Present New Data Evaluating Safety, Tolerability and Immunogenicity of its Investigational Staphylococcus aureus Vaccine Candidate at IDWeek 2014(TM)
Oct 9, 2014 Top 10 Health Care Trends Report Finds Opportunities to Achieve "Triple Aim"
Oct 9, 2014 Kane Biotech Appoints Mark Nawacki to the Board of Directors
Oct 8, 2014 Pfizer and Breast Cancer Leaders Join Together to Increase Understanding and Dispel Myths about Metastatic Breast Cancer
Oct 8, 2014 Pfizer To Present Safety And Immunogenicity Data From A Phase 2 Study Of Its Investigational Meningococcal Group B Vaccine, Bivalent rLP2086, Co-Administered With A Licensed Human Papillomavirus Vaccine
Oct 1, 2014 Portola Pharmaceuticals Announces Phase 3 ANNEXA(TM)-A Study of Andexanet Alfa and Eliquis (Apixaban) Met Primary and Secondary Endpoints With High Statistical Significance
Sep 30, 2014 Positive Study Results, Acquisitions, Drug Approval, Regulatory Updates, and Collaborations - Research Reports on Gilead, Pfizer, AbbVie, Pacira and Thermo Fisher
Sep 30, 2014 Glaucoma Treatment Market 2014-2019 Global Trends & Opportunities Reviewed in New Research Report
Sep 29, 2014 Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study

1
2
3
4
5
6
7
next >

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Haier Biomedical's Strategic Expansion in the U.S.

Nailing the U.S. Market with Cold Precision Haier Biomedical isn't just in the game to compete—they're setting the game rules with their mind-boggling expertise in blood management and pharmaceutical storage solutions. This October, they took center stage at the AABB and ISPE 2026 meetings, and they weren't messing around. Fresh Off the Exhibit Floor: Haier's Ambitions...

Collective Scoops $100M, Powers Solopreneur's Financial Might

Picture This: A Solo Businessman in 2026 Imagine a lone ranger running a show that used to take an entire office. That’s the magic happening with roughly 30 million solo businesses in the U.S. today, and folks, the numbers are staggering. As these one-man-bands push past clunky old systems, a big name is lighting the way: Collective. They raised a hefty $100 million to...

Shield HealthCare Expands Access for Astiva Members

Opening Up New Avenues for Health Care Here's a nugget from the healthcare sector that's worth chewing on. Shield HealthCare has just inked a deal with Astiva Health that opens the floodgates for eligible members in Southern California to access medical supplies through Shield's extensive network. It's a big move that aims to make health management a tad easier for folks...

Luxury Travel Spikes While Budget Trips Take a Hit

Luxury Trips on The Uptrend Luxury travel is surging while budget trips are taking a backseat. According to Squaremouth's latest data, high-end getaways insured for a whopping $30,000 or more shot up by 27.2% in the third quarter of 2026 compared to the same time last year. In contrast, budget-friendly jaunts under $10,000 dipped by 2.3%. Travelers seem ready to splurge...

Hershey's Sweet Results: 2026 Earnings Soar

Hershey's 2026 Q3 Financial Performance: A Closer Look At the end of September, The Hershey Company (NYSE: HSY) dished out some eye-popping numbers for their third quarter. With a net sales increase of 3.0%, they clocked in at $3,275.5 million. More importantly, earnings per share-diluted shot up by a whopping 111.8%, landing at $2.88. Clearly, Hershey’s strategic moves...

BTQ's MIMIQ: A Quantum Leap for 35,000 Developers

Breaking Barriers in Quantum Emulation If you think the quantum computing game is all about hardware, then you're missing half the picture. Enter BTQ Technologies, crash-landing into the scene by throwing open the doors of their MIMIQ emulator to a crowd of over 35,000 quantum developers through qBraid. This ain't just an upgrade—it's a seismic shift. More qubits, more...

HiTHIUM Powers Up Australia's Energy Storage Future

Just imagine, folks, a slice of the energy world reshaping right under our feet in good ol' Australia. That's the buzz HiTHIUM sparked at All Energy Australia as they showcased their fancy ?Power 6.9MWh, 8-hour long-duration battery storage system (BESS). It wasn’t just about the tech superiority but the strategic planting of stakes in the local energy market....

XREAL AURA: A New Era of Wired XR Glasses

Pioneering the XR Frontier Welcome to another day under the sun of cutting-edge tech, where XREAL's striking a chord with its new wired XR glasses—AURA. First off, don't let the tangled history of tech hype get to you. In the wild world of extended reality, we've seen plenty of flash, not enough substance. But XREAL's hitting the market with AURA, and I gotta say,...

Solink Secures $100M: NYSE Sees Tech and Sports Moves

Folks, it’s a busy day on Wall Street, with Solink leading the charge by landing over a cool $100 million in fresh funding. Let's break this down because when startups pocket nine-digit figures, it's time to pay attention. Solink's Leap Forward Now, what’s Solink doing with all that cash? They're not scrambling for coffee money, that's for sure. Instead, this funding...

Circus Circus Vegas Offers Halloween Deals for Families

Halloween at Circus Circus: A New Spin on Family Fun Ah, Circus Circus Las Vegas. It's that place that’s managed to blend screaming kids, excited parents, and a flurry of flashing lights into something resembling an amusement park—on the Strip no less. Now, they're turning up the heat for Halloween. Yup, they're rolling out half-price Midway games and Adventuredome...